US2020129666A1PendingUtilityA1

Variable Density Tissue Graft Composition and Methods of Making and Using the Same

Assignee: ACELL INCPriority: Jul 22, 2009Filed: Dec 30, 2019Published: Apr 30, 2020
Est. expiryJul 22, 2029(~3 yrs left)· nominal 20-yr term from priority
Y10T156/10A61L 2430/34A61F 2210/0004A61L 27/50A61F 2210/0076A61L 27/3633A61F 2/02A61L 27/3604
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are tissue graft compositions made of materials having different densities, methods of making, and methods of treatment for restoring t issues in a patient.

Claims

exact text as granted — not AI-modified
1 - 40 . (canceled) 
     
     
         41 . A method for restoring tissue damage comprising:
 providing a composition comprising a first layer and a second layer, the first layer comprising an extracellular matrix material and a density that differs from the second layer, each of said first layer and said second layer having a first planar surface and a second planar surface, and each of said first and second layers at least partially overlapping the other layer; and,   applying said composition to the damaged tissue.   
     
     
         42 . The method of  claim 41 , wherein said first layer of said composition comprises aponeurosis. 
     
     
         43 . The method of  claim 41 , wherein said first layer comprises a plurality of perforations, each of said perforations comprising a lumen and said second layer is non-perforated, said lumen of the perforations of said first layer enclosing a portion of said second layer whereby said perforated first layer is joined to said non-perforated second layer. 
     
     
         44 . The method of  claim 41 , wherein said first layer comprises epithelial basement membrane. 
     
     
         45 . The method of  claim 44 , wherein said composition is implanted in an abdominal wall of a patient and said epithelial basement membrane is positioned on a peritoneal surface of the abdominal wall. 
     
     
         46 . The method of  claim 41 , wherein said first layer and said second layer has a density that differs from each other in a range of about 400%-125%. 
     
     
         47 . The method of  claim 41 , wherein said first layer and said second layer has a density that differs from each other in a range of about 300%-150%. 
     
     
         48 . The method of  claim 41 , wherein said first layer and said second layer has a density that differs from each other in a range of about 200%-175%. 
     
     
         49 . The method of  claim 41 , wherein said damaged tissue is a joint. 
     
     
         50 . The method of  claim 41 , wherein said damaged tissue is skin. 
     
     
         51 . The method of  claim 41 , wherein said damaged tissue is an abdominal body wall. 
     
     
         52 . The method of  claim 41 , wherein said damaged tissue is a thoracic body wall. 
     
     
         53 . The method of  claim 41 , wherein said damaged tissue is a heart wall. 
     
     
         54 . The method of  claim 41 , wherein said damaged tissue is a vascular vessel wall. 
     
     
         55 . The method of  claim 41 , wherein said damaged tissue is a ligament. 
     
     
         56 . The method of  claim 41 , wherein said damaged tissue is a hernia. 
     
     
         57 . The method of  claim 41 , wherein said damaged tissue is a joint. 
     
     
         58 . The method of  claim 41 , wherein said damaged tissue is a urinary bladder. 
     
     
         59 . The method of  claim 44 , wherein said composition is implanted in a joint of a patient and said epithelial basement membrane is positioned on a synovial surface of said joint. 
     
     
         60 . The method of  claim 44 , wherein said composition is implanted in the wall of a urinary bladder of a patient and said epithelial basement membrane is positioned on the urothelial side of said bladder wall. 
     
     
         61 . The method of  claim 44 , wherein said composition is implanted in the wall of a vessel of a patient and said epithelial basement membrane is positioned on the luminal side of said vessel wall. 
     
     
         62 . The method of  claim 44 , wherein said composition is implanted in the wall of a heart of a patient and said epithelial basement membrane is positioned on the luminal side of said heart wall. 
     
     
         63 . The method of  claim 41 , wherein at least one of said layers of the composition is bioreabsorbed within about 30 days. 
     
     
         64 . The method of  claim 41 , wherein at least one of layers is bioreabsorbed within about 30-120 days. 
     
     
         65 . The method of  claim 41 , wherein said composition further comprises a third layer wherein said first layer is positioned between and joined to said third layer and second layer.

Join the waitlist — get patent alerts

Track US2020129666A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.